Corporate Intelligence & Due Diligence
SEC’s 2026 Examination Priorities for Investment Advisers
On November 17, the U.S. Securities and Exchange Commission (SEC) Division of Examinations (the Division) released its annual examinati...
New BIOSECURE Act Targets Foreign-Linked Biotech
Signaling a major shift in U.S. policy on biotechnology supply chain security, Congress has enacted the BIOSECURE Act as part of the Fi...
OECD Will Hold Webinar on January 15, 2026, on “From Production to End-of-Life: Understanding Fluoropolymers across the Life Cycle”
On January 15, 2026, the Organisation for Economic Co-operation and Development (OECD) will hold a webinar on its recent report, Synthe...
CareFirst’s Class Action STELARA® Antitrust Case Against J&J Will Proceed: Court Grants-in-Part and Denies-in-Part Class Certification and Denies the Parties’ Motions for Summary Judgment
As we have previously reported, a group of health insurers and health insurance administrators (collectively, “CareFirst”) filed a clas...
5 in ‘25: International Trade Commission
The past year at the International Trade Commission (ITC) was anything but ordinary. Here, we highlight five key developments — from su...
Regulatory Considerations in Connection with Clinical Data Release
Publicly sharing clinical results can trigger a range of regulatory and compliance obligations, especially for companies approaching or...
Key Takeaways from FINRA’s 2026 Annual Regulatory Oversight Report – Troutman Pepper Locke
The Financial Industry Regulatory Authority’s (FINRA) 2026 Annual Regulatory Oversight Report is the most current and comprehensive sta...
Regeneron Seeks to Bifurcate or Stay Amgen’s Antitrust Claims in Aflibercept Patent Litigation
On December 11, 2025, Regeneron filed a Memorandum in Support of Its Motion to Bifurcate and Stay Amgen’s Antitrust Claims in the ongoi...
What Trump’s Executive Order to Reschedule Marijuana and CBD Means for the Cannabis Industry
President Donald Trump’s Dec. 18, 2025, executive order “Increasing Medical Marijuana and Cannabidiol Research” directs the Attorney Ge...
ECHA’s Committees Continue to Evaluate PFAS Uses; ECHA Publishes Guidance for Upcoming Consultation on SEAC’s Draft Opinion
The European Chemicals Agency’s (ECHA) Committees for Risk Assessment (RAC) and for Socio-Economic Analysis (SEAC) met in December 2025...